Influence of amesergide treatment on the dextromethorphan test.
| Data(s) |
1994
|
|---|---|
| Identificador |
https://serval.unil.ch/?id=serval:BIB_969F40621D17 isbn:0306-5251 (Print) pmid:7981017 isiid:A1994PA53300012 doi:10.1111/j.1365-2125.1994.tb04340.x |
| Idioma(s) |
en |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
British Journal of Clinical Pharmacology, vol. 38, no. 2, pp. 151-152 |
| Palavras-Chave | #Adult; Antidepressive Agents/pharmacokinetics; Antidepressive Agents/pharmacology; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System/antagonists & inhibitors; Dextromethorphan/pharmacokinetics; Dextromethorphan/pharmacology; Ergolines/pharmacokinetics; Ergolines/pharmacology; Female; Humans; Male; Middle Aged; Mixed Function Oxygenases/antagonists & inhibitors; Phenotype; Serotonin Antagonists/pharmacokinetics; Serotonin Antagonists/pharmacology |
| Tipo |
info:eu-repo/semantics/article article |
